Carman Alenson
Comptroller/Controller/Auditor presso PRIME MEDICINE, INC.
Patrimonio netto: - $ in data 30/04/2024
Posizioni attive di Carman Alenson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| PRIME MEDICINE, INC. | Comptroller/Controller/Auditor | 01/08/2021 | - |
| Direttore Finanziario/CFO | 01/08/2021 | 17/01/2024 |
Storia della carriera di Carman Alenson
Precedenti posizioni note di Carman Alenson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 07/11/2016 | 30/07/2021 |
| AMAG PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2015 | 01/10/2016 |
Formazione di Carman Alenson
| Boston University | Masters Business Admin |
Statistiche
Distribuzione geografica
| Stati Uniti | 4 |
| Israele | 2 |
Posizioni
| Comptroller/Controller/Auditor | 3 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| PRIME MEDICINE, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Borsa valori
- Insiders
- Carman Alenson
- Esperienza
